Nymox Pharmaceutical Market Cap

Nymox Pharmaceutical has a market cap or net worth of $8.51 million as of February 21, 2025. Its market cap has decreased by -81.81% in one year.

Market Cap

8.51M

Enterprise Value

11.07M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.09

Market Cap Chart

Since November 26, 1997, Nymox Pharmaceutical's market cap has decreased from 118.04M to 8.51M, a decrease of -92.79%. That is a compound annual growth rate of -9.20%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	8.51M	-10.00%
Dec 31, 2024	9.45M	-82.82%
Dec 29, 2023	55.03M	86.49%
Dec 30, 2022	29.51M	-73.23%
Dec 31, 2021	110.23M	-42.54%
Dec 31, 2020	191.84M	24.63%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	2.19B
SS Innovations International	1.72B
Nika Pharmaceuticals	1.02B
Veradigm	864.81M
Elite Pharmaceuticals	520.73M
Glass House Brands	497.07M
CytoDyn	367.12M
Northwest Biotherapeutics	326.95M

Market Cap Rankings